Company Overview and News

10
Cedar Realty Acquires Leasehold Stake in Senator Square

2018-08-29 zacks
Recently, Cedar Realty Trust, Inc. (CDR - Free Report) announced that it has acquired a 99-year leasehold interest, including an option to purchase, at the Senator Square Shopping Center. This transaction reflects the company’s efforts to significantly expand and redevelop its properties in the vibrant neighborhood of Ward 7, as well as Washington, D.C.
CDR VICI PSB PSEC URBN PBB

 
Cedar Realty Trust, Inc. (CDR) CEO Bruce Schanzer on Q2 2018 Results - Earnings Call Transcript

2018-08-03 seekingalpha
Cedar Realty Trust, Inc. (NYSE:CDR) Q2 2018 Earnings Conference Call August 2, 2018 5:00 PM ET
CDR

 
Cedar Realty Trust (CDR) Q2 Earnings and Revenues Beat Estimates

2018-08-02 zacks
Cedar Realty Trust (CDR - Free Report) just came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.
CDR SHAK

 
CDR / Cedar Realty Trust, Inc. 10-Q (Quarterly Report)

2018-08-02 sec.gov
cdr-10q_20180630.htm UNITED STATES
CDR

 
CDR / Cedar Realty Trust, Inc. 8-K (Current Report)

2018-08-02 sec.gov
cdr-8k_20180802.htm UNITED STATES
CDR

 
CDR / Cedar Realty Trust, Inc. null

2018-07-26 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C
CDR

 
CDR / Cedar Realty Trust, Inc. null

2018-07-26 sec.gov
CORRESP Via Edgar Kristi Marrone Staff Accountant Office of Real Estate and Commodities Securities and Exchange Com
CDR

 
CDR / Cedar Realty Trust, Inc. null

2018-07-26 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0T(# @;V)J#3P\+TQI;F5A(2 02["5 XG,3 Q,CPVZ0+ ,C >(_X\R? $& .Q0!NL- M"F5N9'-T
CDR

1
Weekly CEF Roundup: Cuts And Boosts To BlackRock And Nuveen CEFs

2018-07-22 seekingalpha
20 CEF sectors out of 31 positive on price, and 29 out of 31 sectors positive on NAV.
BLJ AEF CDR FSD FHY DTK MYJ BNJ RVT.WI NTG NBD RVT NBB

18
Is a Hold Strategy Appropriate for Alexandria (ARE) Now?

2018-07-18 zacks
Alexandria Real Estate Equities, Inc. (ARE - Free Report) is expected to enjoy high demand and occupancy for its portfolio of Class A properties in AAA locations, going forward. Further, focus to expand its life-science clusters in key markets is anticipated to drive the company’s performance over the long term.
ARE CDR GEC GE GNE VICI

3
Liberty Property to Open Distribution Center in Charlotte

2018-07-17 zacks
Liberty Property Trust (LPT - Free Report) recently announced its plans to break ground on a distribution center at 12830 Virkler Drive in Charlotte’s southwest submarket in August. The 115,500 square foot, Class A and LEED Certified, distribution center is expected to be ready by the first quarter of 2019. This 32-foot high and 210-foot deep property will be developed jointly by DMA Architecture, Burton Engineering and Landmark Builders.
CDR LPT VICI

 
An Example Of A Working Pair Trade: Cedar Realty Trust

2018-07-06 seekingalpha
Instead of trying to determine the right direction, we found a way to participate utilizing arbitrage.
CDR

5
CDR / Cedar Realty Trust, Inc. FORM 8-K (Current Report)

2018-06-18 sec.gov - 3
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
CDR

2
CDR / Cedar Realty Trust, Inc. FORM 8-K (Current Report)

2018-06-12 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
CDR

4
CDR / Cedar Realty Trust, Inc. FORM 8-K (Current Report)

2018-05-07 sec.gov - 2
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
CDR

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CDR / Cedar Realty Trust, Inc. on message board site Silicon Investor.

NCDR NCDR NCDR CALDERA RESOURCES - CDR.T CALDERA RESOURCES - CDR.T CALDERA RESOURCES - CDR.T
CDRD (CD Radio) CDRD (CD Radio) CDRD (CD Radio) Caldarau0027s Diamond CDR,M Caldarau0027s Diamond CDR,M Caldarau0027s Diamond CDR,M
Verify of a CDR Verify of a CDR Verify of a CDR CD Radio (CDRD) A FLOOD OF STOCK CD Radio (CDRD) A FLOOD OF STOCK CD Radio (CDRD) A FLOOD OF STOCK
Caldera Resources Inc. Caldera Resources Inc. Caldera Resources Inc.
CUSIP: 150602209